July 10, 2026

How to Turn a $200M Company Into $12.8 Billion

Show Notes

Jeff Park spent over a decade transforming SKC Health Solutions into Catamaran, a pharmacy benefits technology company that sold to UnitedHealthcare for $12.8 billion, a 65 times return on the original investment. He did it through 14 plus acquisitions, a relentless integration playbook, and one core belief: people are the only competitive advantage.

In this episode of No Spotlight Needed, Jeff walks through how he earned the right to speak as a 25 year old sitting on ten boards, what the IPO taught him about investor storytelling, how to compete with your own customers and win, the three filters behind every M&A decision, why culture kills deals and how they stopped it, and what a year and a half in Portugal taught him about what actually matters.

Let's connect:
LinkedIn: / sheetal-mehta-prasad
Our Website: https://www.nospotlightneeded.com
Subscribe to the Channel: / @nospotlightneeded

Timestamps:

1:27 - Introduction: Jeff Park and the SKC to Catamaran story
2:33 - Welcome and what Waltz Health does
3:09 - One drug, 2200 different prices: the problem Waltz is solving
4:27 - 14 million lives, $300 million saved: what it looks like in practice
5:25 - Starting in venture capital at Covington Capital in his 20s
6:31 - Sitting on ten boards as a 25 year old: what he actually contributed
8:17 - How to earn the right to speak when you are the youngest in the room
9:14 - The leverage equation: diligence before the check, none after
9:55 - Making the leap from investor to operator as CFO of SKC
10:51 - What he thought the job would look like versus what it actually was
11:09 - IPO lessons: who tells your story after the roadshow matters more than the bank name
12:03 - Why JPMorgan was the wrong choice for a $200M market cap company
12:20 - The Cory Tobin lesson: it is okay to say I do not know
13:45 - The post-it note Jeff carried on every earnings call for ten years
14:59 - At what point did they decide to become a PBM and compete with their own customers?
15:23 - The Formula One car in the lobby and the moment everything changed
16:44 - The first acquisition: NMC in 2008 for $143 million, all chips in
17:47 - Competing with clients: the pathway to control as the kill shot
19:52 - The M&A playbook: the three filters for every deal
20:52 - Why people retention is the real integration risk
21:13 - Tripling the EBITDA on NMC and turning skeptics into believers
21:39 - The integration playbook: one answer, one process, one platform
22:03 - Friday morning executive standups that ran for ten years
23:37 - How they knew the organization was ready for the next deal
24:54 - NMC to Catalyst: a $143M deal followed by a $4.4B deal
25:38 - The culture problem inside Catalyst: Sox fans and Cubs fans
26:57 - Changing the company name entirely and why it mattered
27:40 - Day one actions: the 90 day window that defines integration success
28:01 - Building a combined leadership team from both sides
29:39 - Selling to UnitedHealthcare for $12.8 billion
30:03 - What Jeff loved about United and why he still left after a year
31:02 - At 45 with kids aged 10 and 13, the decision to move to Portugal
34:02 - What you realize when you are never fully present anywhere
35:38 - A year and a half of reflection: how do I define myself when I am not working?
36:10 - Three things he decided he wanted from every chapter going forward
37:34 - The Welldyne opportunity: chairman and CEO, Carlyle backed, rinse and repeat
39:03 - Recruiting 40 former employees and building again from scratch
39:36 - If you are not buying you are dying: the PBM reality
41:01 - The FTC investigation and the real problem with PBM scale
42:00 - $600 billion in drug spend, $100 billion paid by patients, 100 million abandoned prescriptions
43:18 - What regulation actually creates: the conditions for disruption
44:16 - The Jeff and Mark dynamic: what makes a 20 year partnership work
45:32 - Joining Waltz Health: the right people, the right problem, the right moment